Portal26 offers a comprehensive GenAI Adoption Management Platform aimed at helping enterprises safely and effectively scale generative-AI initiatives. Its product suite spans real-time ShadowAI detection, security and policy enforcement, forensic audit, risk management, intent and use-case analysis, cost and license analytics, GenAI strategy, policy management, and employee education. The platform, available in both standalone and integration-based deployments, already monitors hundreds of thousands of enterprise GenAI users. Many customers have signed multi-year commitments worth up to seven figures, reflecting strong market confidence. Portal26 also maintains partnerships across security vendors, systems integrators, resellers, and hyperscalers to extend its reach. Proceeds from the latest financing will support further product innovation and accelerated growth. To date, the company has raised $15 million, including a $6 million seed round in 2022 and the newly announced Series A.

Total raised

$9M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2025